Previous 10 | Next 10 |
2024-01-16 10:50:09 ET Summary Investors are monitoring the S&P 500 stocks as the index starts the year with a pullback and uncertainty over interest rate cuts. Top-performing stocks include Juniper, Nvidia, Eli Lilly, Viatris, and Organon, while solar energy stocks and Boeing...
2024-01-16 08:19:18 ET Orbicular Pharmaceutical Technologies has agreed to resolve its patent fight with Theravance Biopharma ( NASDAQ: TBPH ) and Viatris ( NASDAQ: VTRS ) unit, Mylan, over the respiratory disorder therapy Yupelri. Per the terms of the agreement, Orbicul...
2024-01-16 03:58:00 ET Summary In December 2023, we received $6,884.70 in dividend income. The majority of our dividend income this month came from funds. Johnson & Johnson, Target, and T. Rowe Price were clearly the top 3 individual stock payers. December is alw...
2024-01-14 08:04:48 ET Summary Viatris stock has been on the rise, up over 20% in the past month, reaching its highest price since February 2023. The company's revenues are derived from established brands, generics, and complex generics, with a significant portion coming from pate...
2024-01-12 12:54:48 ET Summary Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' dividend yield is 3.97%, which is attractive becaus...
2024-01-12 01:06:36 ET Summary Invesco S&P 500 Pure Value ETF holds large cap value stocks with little or no growth characteristics. It is well-diversified across holdings, but overweight in the financial sector. Valuation metrics look attractive, but RPV has lagged the S&...
2024-01-10 18:50:01 ET Viatris Inc. (VTRS) J.P. Morgan 42nd Annual Healthcare Conference January 10, 2024 01:30 PM ET Company Participants Scott A. Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conference Call Participants Chris Schott - J....
2024-01-10 15:35:59 ET More on Viatris Viatris Stock Is Dirt Cheap And Worth Buying Viatris: It Is Always Cheap, Yet It Is Always Declining Viatris Inc. 2023 Q3 - Results - Earnings Call Presentation Regeneron gains after mixed ruling in patent suit over Eyle...
2024-01-09 03:16:00 ET Summary In December, we (my wife and I) received a dividend income total of $10,193.04. Crossed the $10k threshold, again. Vanguard’s High Dividend Yield ETF, which we have been buying for 3.5 years, literally has paid immense dividends. In total,...
2024-01-07 12:00:45 ET More on AbbVie, Bristol-Myers, etc. AbbVie: Still Expensive Despite The Great M&A Acumen Bristol-Myers Squibb Company (BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Health...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...